The envisioned flow cytometry test will help to predict patient response to immunotherapies for five cancer indications.

Laboratory Developed Tests (LDTs) are critical for diagnosing rare diseases and addressing unmet clinical needs. They are developed, manufactured, ...

Researchers developed a wearable pad that detects inflammation and cancer biomarkers in menstrual blood using smartphone ...

The company's flagship assay uses whole-genome sequencing to identify patients with high-risk multiple myeloma and determine which patients won't respond to therapies.

A first-of-its-kind blood test developed by Malvern-based Fujirebio Diagnostics to help diagnose Alzheimer’s disease has ...

In a proof-of-concept study, the test successfully identified five critical biomarkers associated with Alzheimer’s disease, ...

Canadian scientists have developed a blood test and portable device that can determine the onset of sepsis faster and more ...

According to district surveillance officer Dr N Nirav, the patient had recently returned from a trip to Uttarakhand on May 14 ...

A team at the University of Melbourne in Australia has developed a new blood test for the diagnosis of rare genetic diseases ...

ROURKELA: In what could revolutionise early breast cancer detection for effective and timely cancer management, researchers ...

David AuCoin, Ph.D., shares insights from his lab’s work developing prototype rapid diagnostic tests for infectious diseases ...